Toshihiko Sugiura

Title: The Innovations of Toshihiko Sugiura

Introduction

Toshihiko Sugiura is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of ulcerative colitis. With a total of three patents to his name, Sugiura's work reflects a commitment to advancing medical science.

Latest Patents

One of Sugiura's latest patents is a pharmaceutical composition for treating ulcerative colitis. This composition comprises a compound represented by a specific formula or a pharmaceutically acceptable salt thereof. The compound is administered in an amount of 600 mg or more per day to patients suffering from ulcerative colitis. Another significant patent is related to a sulfonamide derivative and its medicinal use. This patent describes sulfonamide compounds with a specific chemical structure, which includes a sulfonamide group with a phenyl or heterocyclic group as a substituent. These novel compounds exhibit excellent α4 integrin-inhibitory action, showcasing their potential in therapeutic applications.

Career Highlights

Throughout his career, Toshihiko Sugiura has worked with prominent companies in the pharmaceutical industry, including Ea Pharma Co., Ltd. and Ajinomoto Co., Ltd. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Sugiura has collaborated with several talented individuals in his field, including Shunsuke Kageyama and Takashi Yamamoto. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Toshihiko Sugiura's contributions to pharmaceutical innovation are noteworthy. His patents reflect a dedication to improving treatments for conditions like ulcerative colitis. Through his work, Sugiura continues to impact the medical field positively.